SETBP1 and developmental and epileptic encephalopathy: Furthermore, the loss‐of‐function mutations in SETBP1 have also been reported to be associated with intellectual disability, expressive language disorders, childhood aphasia, autism spectrum disorders, neurodevelopmental disorders, and developmental epileptic encephalopathy (Antonyan & Ernst, 2022; Coe et al., 2014; Filges et al., 2011; Jansen et al., 2021; Leonardi et al., 2020; Morgan et al., 2021; Rakhlin et al., 2020; Wong et al., 2022).